Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03283943
Title PDL-1 Inhibition and Focal Sensitizing Radiotherapy in Recurrent Ovarian/Primary Peritoneal/Fallopian Tube Cancers.
Recruitment Unknown status
Gender female
Phase Phase I
Variant Requirements No
Sponsors British Columbia Cancer Agency
Indications
Therapies
Age Groups:
Covered Countries CAN

Facility Status City State Zip Country Details
BC Cancer Agency RECRUITING Vancouver British Columbia V5Z 4E6 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field